Recently, there are several researches in Hela cells, breast cancer, colon carcinoma and melanoma showing CCL2/CCR2 axis is related to the activation of MAPK pathways in ERK1/2, p38, and JNK [42, 50–52]. Here, CCL2 is linked to breast carcinoma.